Home›Companies›Nurocor

Nurocor Inc

Updated Oct 29, 2026·Latest SEC filing May 22, 2025·Suggest an edit

About Nurocor

Nurocor is a private company based in Austin, Texas. It has reported $6,635,000 raised in seven offerings on Form D since June 2022.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 29, 2025May 22, 2025$460,000of $3.0M target8$57,500Debt, Securities on exerciseRule 506(b)Form D ↗
Feb 28, 2025Apr 2, 2025$500,000fully sold1$500KSecurities on exerciseRule 506(b)Form D ↗
Jan 23, 2025Feb 28, 2025$125,000fully sold1$125KOptionsRule 506(b)Form D ↗
Oct 7, 2024Feb 28, 2025$250,000fully sold1$250KOptionsRule 506(b)Form D ↗
Sep 22, 2023Oct 17, 2024$4,950,000of $7.5M target27$183KEquityRule 506(b)Form D ↗
Sep 11, 2024Oct 17, 2024$350,000fully sold1$350KDebtRule 506(b)Form D ↗
Not yetJun 10, 2022$0target not set0—Debt, OptionsRule 506(b)Form D ↗
Total, seven offerings$6,635,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Nurocor's Form D filed May 22, 2025.

GM
Gregg Martin
Executive officer and director
PG
Paul Gigg
Chairman
AL
Alex Lazar
Executive officer and director

Earlier filings also listed Greg Martin (executive officer and director, last listed Feb 2025).

Sources

  1. SECNurocor Inc filing history